Article
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression
1 Jan 2020
Abstract excerpt
BACKGROUND: Tumor heterogeneity underlies resistance and disease progression in glioblastoma (GBM), and tumors most commonly recur adjacent to the surgical resection margins in contrast non-enhancing (NE) regions. To date, no targeted therapies have meaningfully altered overall patient survival in the up-front setting. The aim of this study was to characterize intratumoral heterogeneity in recurrent GBM using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
